The Egyptan International Company for Pharma Industries (EIPICO) will start production on its third plant in May, thelocal press reports. The factory, based in the Tenth of Ramadan City, cost EIPICO EGP 1 bn and is expected to contribute to the government’s fight against the covid-19 outbreak by producing genetically modified proteins.
More from Enterprise
The National Bank of Egypt and Banque Misr just hiked rates on CDs — moves that could see the EGP gain against the USD
NBE and BM both hiked rates on CDs by 125…
Qatar’s Green Sky Capital secures financing for USD 200 mn SAF plant
The facility could add more than 10% to global SAF…
EGX30 erases March losses with 14.2% April surge
The rally piled on roughly EGP 433 bn in market…
Kiwe gets Central Bank green light to launch nationwide
The startup is backed by our friends at EFG Hermes,…